Drugs / Pantovigar
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01900041 | Apr 2012 → May 2013 | androgenetic alopecia | Merz Pharmaceuticals GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pantovigar | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01900041 ↗ |
| Route | Oral | “for oral intake” NCT01900041 ↗ |